Evidence map›Paper›PMID 35740610›Full record

ArticleCancers2022

Psychological Impact of

Amanda Scartezini Gozdziejewski, Clarice Wichinescki Zotti, Isabela Aparecida Moreira de Carvalho, Thairine Camargo Dos Santos, Luana Rayana de Santi Walter, Karin Rosa Persegona Ogradowski, Karin Luiza Dammski, Heloisa Komechen, Monalisa Castilho Mendes, Emanuelle Nunes de Souza and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Amanda Scartezini GozdziejewskiPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.ORCID 0000-0003-3936-199X
Clarice Wichinescki ZottiPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Isabela Aparecida Moreira de CarvalhoFaculdades Pequeno Príncipe, 333 Iguaçu Av., Rebouças, Curitiba 80230-902, PR, Brazil.
Thairine Camargo Dos SantosFaculdades Pequeno Príncipe, 333 Iguaçu Av., Rebouças, Curitiba 80230-902, PR, Brazil.
Luana Rayana de Santi WalterFaculdades Pequeno Príncipe, 333 Iguaçu Av., Rebouças, Curitiba 80230-902, PR, Brazil.
Karin Rosa Persegona OgradowskiPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Karin Luiza DammskiPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Heloisa KomechenPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Monalisa Castilho MendesPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Emanuelle Nunes de SouzaPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Mariana Martins ParaizoPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Ivy Zortea da Silva ParisePelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Guilherme Augusto ParisePelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
André Luiz GrionPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Gislaine CustódioCentro de Genética Molecular e Pesquisa do Câncer em Crianças (CEGEMPAC), UFPR, 400 Agostinho Leão Jr. Av., Curitiba 80030-110, PR, Brazil.
Rosiane Guetter MelloPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.
Bonald C FigueiredoPelé Pequeno Príncipe Research Institute, 1532 Silva Jardim, AV., Curitiba 80250-200, PR, Brazil.ORCID 0000-0002-1051-2056
Hospital IPO · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Counselling and genetic testing (CGT) after neonatal screening may increase depression and anxiety (DA) levels during cancer surveillance. This study assessed the DA scores in mothers of newborns from Paraná state, Southern Brazil, carrying the

Indexed as

anxietydepressiongenetic counsellingpredictive testingTP53 p.R337H mutation

Identifiers

PMID35740610
PMCPMC9221115
OpenAlexW4282940570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.